Nasdaq:MDLN
Medline Inc.
A global healthcare distributor dominating the medical supply market with robust cash flow and a massive product catalog serving hospitals and clinics.
Key Metrics
Investment Thesis
Bull Case
Investors should consider buying MDLN due to its massive market share and pricing power in an industry with consistent demand for essential medical supplies. The company's ability to generate $1.74 billion in operating cash flow provides a stable dividend base and flexibility for strategic acquisitions or debt reduction. Its diversified product mix and global reach offer protection against regional economic downturns, making it a defensive growth stock.
Bear Case
The low-margin nature of the disposable medical supply business exposes MDLN to significant margin compression from competitive bidding and payer cost-cutting initiatives. High levels of goodwill ($8.08 billion) and other non-cash adjustments suggest potential impairment risks if market dynamics shift or customer concentration increases. The company's heavy reliance on a few large hospital customers means that any loss of key accounts could materially impact annual revenue growth.
About Medline Inc.
Medline Industries Inc. is a leading global distributor of medical and healthcare products, serving hospitals, nursing homes, and independent clinics worldwide. The company leverages its extensive supply chain network to distribute a vast catalog of disposable medical supplies, durable medical equipment, and patient care solutions. With strong cash generation and a dominant market position, Medline provides essential products that support the healthcare ecosystem.
Analysis
Management Discussion
Medline reported revenue of $28.43 billion with a net profit of $1.16 billion, demonstrating resilient performance despite potential headwinds in the healthcare supply chain. The company generated substantial operating cash flow of $1.74 billion, which was partially reinvested into capital expenditures of $447 million and used to pay down debt or return value to shareholders. While non-operating losses impacted net income, the core business operations remained highly profitable with a strong balance sheet.
Industry Overview
The medical device and supply distribution industry is characterized by high barriers to entry due to the complexity of logistics, regulatory compliance, and relationships with major healthcare providers. Consolidation is ongoing as larger players acquire smaller distributors to expand their product catalogs and improve economies of scale. Demand remains steady driven by an aging population and increased adoption of advanced patient care technologies.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2025 |
|---|---|
| Revenue | $28.43B |
| Cost of Revenue | $20.91B |
| Gross Profit | $7.52B |
| Operating Expenses | $5.31B |
| Operating Income | $2.21B |
| R&D | $80.0M |
| G&A | $4.52B |
| Stock-Based Comp | $76.0M |
| D&A | $1.01B |
| Depreciation | $307.0M |
| Amortization | $704.0M |
| Other OpEx | $702.0M |
| Non-Operating Income | $-964.0M |
| Interest Income | $133.0M |
| Pre-Tax Income | $1.25B |
| Income Tax | $91.0M |
| Continuing Ops | $1.16B |
| Discontinued Ops | $2.0M |
| Net Income | $1.16B |
| Minority Interest | $0 |
| Net to Common | $1.16B |
| Metric | 2025 |
|---|---|
| Current Assets | $10.68B |
| Cash & Equivalents | $1.94B |
| Accounts Receivable | $3.53B |
| Inventory | $4.77B |
| Other Current Assets | $438.0M |
| Long-Term Assets | $27.80B |
| PP&E (Net) | $4.78B |
| Intangibles | $13.89B |
| Goodwill | $8.08B |
| Operating Leases | $432.0M |
| Other LT Assets | $623.0M |
| Total Assets | $38.48B |
| Current Liabilities | $2.49B |
| Accounts Payable | $961.0M |
| Current Debt | $76.0M |
| Current Leases | $66.0M |
| Taxes Payable | $24.0M |
| Other Current Liab | $-89.0M |
| Long-Term Liabilities | $16.71B |
| Long-Term Debt | $12.48B |
| LT Operating Leases | $386.0M |
| Other LT Liab | $3.84B |
| Total Liabilities | $19.20B |
| Shareholders' Equity | $19.29B |
| Paid-In Capital | $10.72B |
| Retained Earnings | $-7.0M |
| AOCI | $27.0M |
| Total L&E | $38.48B |
| Metric | 2025 |
|---|---|
| Net Income (CFO) | $1.16B |
| Non-Cash Adjustments | $-122.0M |
| Working Capital Changes | $707.0M |
| Cash from Operations | $1.74B |
| Capital Expenditures | $447.0M |
| Cash from Investing | $-474.0M |
| Share Buybacks | $33.0M |
| Cash from Financing | $399.0M |
| FX Effect | $23.0M |
| Net Change in Cash | $1.69B |
| Beginning Cash | $250.0M |
| Ending Cash | $1.94B |
Frequently Asked Questions
How does Medline Inc. make money?
The company's revenue is driven by its broad distribution of disposable medical supplies (gloves, masks, gowns), durable medical equipment such as hospital beds and mobility aids, and specialized patient care solutions including wound care and infection control products. Its extensive network allows it to serve a diverse customer base ranging from acute care hospitals to home health providers.
What are the main risks for MDLN?
The healthcare sector faces intense pricing pressure as payers seek to reduce costs, which could compress the company's already thin gross margins on low-margin consumable goods. Regulatory changes in Medicare reimbursement rates or new environmental regulations regarding medical waste disposal could impact sales volume and operational compliance costs. A significant portion of revenue comes from a limited number of large hospital customers, creating concentration risk if key accounts switch vendors or reduce spending.
What is MDLN's competitive advantage?
Medline possesses one of the largest product catalogs in the healthcare industry, allowing customers to source nearly everything they need from a single vendor. The company benefits from significant economies of scale in logistics and distribution, resulting in lower operating costs per unit compared to smaller competitors. Its strong relationships with major manufacturers and established contracts provide high barriers to entry for new rivals.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.